Federation des caisses Desjardins du Quebec’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $830K | Buy |
|
|||||
|
2025
Q2 | $465K | Sell |
|
|||||
|
2025
Q1 | $1.52M | Buy |
|
|||||
|
2024
Q4 | $951K | Buy |
|
|||||
|
2024
Q3 | $604K | Buy |
|
|||||
|
2024
Q2 | $626K | Buy |
|
|||||
|
2024
Q1 | $458K | Buy |
|
|||||
|
2023
Q4 | $400K | Sell |
|
|||||
|
2023
Q3 | $526K | Sell |
|
|||||
|
2023
Q2 | $570K | Sell |
|
|||||
|
2023
Q1 | $705K | Buy |
|
|||||
|
2022
Q4 | $250K | Buy |
|
|||||
|
2022
Q3 | $180K | Sell |
|
|||||
|
2022
Q2 | $191K | Sell |
|
|||||
|
2022
Q1 | $184K | Buy |
|
|||||
|
2021
Q4 | $193K | Hold |
|
|||||
|
2021
Q3 | $169K | Buy |
|
|||||
|
2021
Q2 | $54.2K | Sell |
|
|||||
|
2021
Q1 | $127K | Sell |
|
|||||
|
2020
Q4 | $152K | Buy |
|
|||||
|
2020
Q3 | $57.1K | Buy |
|
|||||
|
2020
Q2 | $43.2K | Hold |
|
|||||
|
2020
Q1 | $29.6K | Hold |
|
|||||
|
2019
Q4 | $29.6K | Hold |
|
|||||
|
2019
Q3 | $23.6K | Hold |
|
|||||
|
2019
Q2 | $30K | Hold |
|
|||||
|
2019
Q1 | $31.1K | Hold |
|
|||||
|
2018
Q4 | $29.8K | Hold |
|
|||||
|
2018
Q3 | $33.9K | Hold |
|
|||||
|
2018
Q2 | $33K | Hold |
|
|||||
|
2018
Q1 | $28.4K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $9.31K | Hold |
|
|||||
|
2017
Q2 | $9.08K | Hold |
|
|||||
|
2017
Q1 | $8.78K | Buy |
|